Cargando…
Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates
Leishmaniasis is a tropical disease caused by a protozoan parasite Leishmania that is transmitted via infected female sandflies. At present, leishmaniasis treatment mainly counts on chemotherapy. The currently available drugs against leishmaniasis are costly, toxic, with multiple side effects, and l...
Autores principales: | Jain, Surbhi, Sahu, Utkarsha, Kumar, Awanish, Khare, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416627/ https://www.ncbi.nlm.nih.gov/pubmed/36015216 http://dx.doi.org/10.3390/pharmaceutics14081590 |
Ejemplares similares
-
Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection
por: Khare, Prashant, et al.
Publicado: (2020) -
Proteomics in Host-Protozoan Parasite Interactions and Development of Drug and Vaccine
por: Kumar, Awanish
Publicado: (2021) -
Drug-Induced Lipid Remodeling in Leishmania Parasites
por: Gutierrez Guarnizo, Sneider Alexander, et al.
Publicado: (2021) -
Role of Cytokines in Experimental and Human Visceral Leishmaniasis
por: Samant, Mukesh, et al.
Publicado: (2021) -
Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection
por: Sahu, Utkarsha, et al.
Publicado: (2021)